According to reports, the use of monoclonal antibodies that obstruct PD-l/PD-L1 binding can greatly increase NK cells’ cytotoxicity and their ability to produce immunosuppressive cytokines, which in turn stunts the growth and spread of tumor cells. The gene discussed is CD274; the disease is neoplasm.